DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 088639
NDA 088639 describes MEPERIDINE HYDROCHLORIDE, which is a drug marketed by Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Barr, Duramed Pharms Barr, Epic Pharma, Mikart, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, Wyeth Ayerst, Hospira, and Icu Medical Inc, and is included in forty-two NDAs. It is available from seven suppliers. Additional details are available on the MEPERIDINE HYDROCHLORIDE profile page.
The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
Summary for 088639
| Tradename: | MEPERIDINE HYDROCHLORIDE |
| Applicant: | Barr |
| Ingredient: | meperidine hydrochloride |
| Patents: | 0 |
| Therapeutic Class: | Analgesics |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 088639
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 088639
Suppliers and Packaging for NDA: 088639
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 088639 | ANDA | Teva Pharmaceuticals USA, Inc. | 0555-0381 | N | 0555-0381-02 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Jul 2, 1984 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
